Controllable Laser Ion Acceleration

In this paper a future laser ion accelerator is discussed to make the laser-based ion accelerator compact and controllable. Especially a collimation device is focused in this paper. The future laser ion accelerator should have an ion source, ion collimators, ion beam bunchers, and ion post acceleration devices [Laser Therapy 22, 103(2013)]: the ion particle energy and the ion energy spectrum are controlled to meet requirements for a future compact laser ion accelerator for ion cancer therapy or for other purposes. The energy efficiency from the laser to ions is improved by using a solid target with a fine sub-wavelength structure or a near-critical density gas plasma. The ion beam collimation is performed by holes behind the solid target or a multi-layered solid target. The control of the ion energy spectrum and the ion particle energy, and the ion beam bunching would be successfully realized by a multistage laser-target interaction

Novel internal measurements of ion cyclotron frequency range fast-ion driven modes

Novel internal measurements and analysis of ion cyclotron frequency range fast-ion driven modes in DIII-D are presented. Observations, including internal density fluctuation (˜n) measurements obtained via Doppler backscattering, are presented for modes at low harmonics of the ion cyclotron frequency localized in the edge. The measurements indicate that these waves, identified as coherent ion cyclotron emission (ICE), have high wave number, k⊥ρfast1, consistent with the cyclotron harmonic wave branch of the magnetoacoustic cyclotron instability, or electrostatic instability mechanisms. Measurements show extended spatial structure (at least ∼1/6 the minor radius). These edge ICE modes undergo amplitude modulation correlated with edge localized modes (ELM) that is qualitatively consistent with expectations for ELM-induced fast-ion transport

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Diels–Alder Reactions with Ethylene and Superelectrophiles

Diels–Alder reactions have been accomplished with ethylene as the dienophile through the use of inverse-electron demand Diels–Alder chemistry. As a key aspect of the chemistry, the dienes are part of tri- or dicationic superelectrophilic systems. Theoretical calculations reveal that the highly charged superelectrophiles possess exceptionally low lying LUMOs, and this facilitates the cycloaddition chemistry with ethylene. The chemistry has been used to prepare a series of tetrahydro­quinoline products. This represents the first application of superelectrophilic activation in a cycloaddition reaction, and a new method of utilizing ethylene as a C₂ building block

Efficient ion generation in laser-foil interaction

A remarkable improvement is presented on the energy conversion efficiency from laser to protons in a laser-foil interaction by particle simulations. The total laser-proton energy conversion efficiency from laser to protons becomes 16.7%, though a conventional plane foil target serves a rather low efficiency. In our 2.5-dimensional particle-in-cell simulations the Al multihole structure is also employed, and the laser absorption ratio reaches 71.2%. The main physical reason for the enhancement of the conversion efficiency is a reduction of the laser reflection at the target surface area

Laser-plasma booster for ion post acceleration

A remarkable ion energy increase is demonstrated for post acceleration by a laser-plasma booster. An intense short-pulse laser generates a strong current by high-energy electrons accelerated, when this intense short-pulse laser illuminates a plasma target. The strong electric current creates a strong magnetic field along the high-energy electron current in plasma. During the increase phase in the magnetic field, a longitudinal inductive electric field is induced for the forward ion acceleration by the Faraday law. Our 2.5-dimensional particle-in-cell simulations demonstrate a remarkable increase in ion energy by several tens of MeV

Efficient ion generation in laser-foil interaction

A remarkable improvement is presented on the energy conversion efficiency from laser to protons in a laser-foil interaction by particle simulations. The total laser-proton energy conversion efficiency from laser to protons becomes 16.7%, though a conventional plane foil target serves a rather low efficiency. In our 2.5-dimensional particle-in-cell simulations the Al multihole structure is also employed, and the laser absorption ratio reaches 71.2%. The main physical reason for the enhancement of the conversion efficiency is a reduction of the laser reflection at the target surface area

The Natural History of Incidental Colonic Diverticulosis on Screening Colonoscopy

Background. The natural history of colonic diverticulosis is unclear. Methods. Patients with incidental diverticulosis identified in a previous prospective cross-sectional screening colonoscopy study were evaluated retrospectively for clinic or hospital visit(s) for diverticular disease (DD= acute diverticulitis or diverticular bleeding) using review of electronic health records and patient phone interview. Results. 826 patients were included in the screening colonoscopy study. Three were excluded for prior DD. In all, 224 patients (27.2%; mean age 62.3 ± 8.2) had incidental diverticulosis distributed in the left colon (67.4%), right colon (5.8%), or both (22.8%). Up-to-date information was available on 194 patients. Of those, 144 (74.2%) could be reached for detailed interview and constituted the study population. Over a mean follow-up of 7.0 ± 1.7 years, DD developed in 6 out of 144 patients (4.2%) (4 acute cases of diverticulitis, 1 probable case of diverticular bleeding, and 1 acute case of diverticulitis and diverticular bleeding). Two patients were hospitalized, and none required surgery. The time to event was 5.1 ± 1.6 years and the incidence rate was 5.9 per 1000 patient-years. On multivariate analysis, none of the variables collected at baseline colonoscopy including age, gender, obesity, exercise, fiber intake, alcohol use, constipation, or use of NSAIDs were associated with DD. Conclusion. The natural history of incidental diverticulosis on screening colonoscopy was highly favorable in this well-defined prospectively identified cohort. The common scenario of incidental diverticulosis at screening colonoscopy makes this information clinically relevant and valuable to physicians and patients alike